Expedio™ Hereditary Cancer Risk Testing
Hereditary Cancer Risk
CommercialActive
Key Facts
About Kailos Genetics
Kailos Genetics is a private, commercial-stage diagnostics company enabling precision medicine through integrated genetic testing services and reagent products. Its core business is built on a dual model: offering direct-to-provider clinical tests like Expedio™ for hereditary cancer and Inspexion™ for pharmacogenomics, while also supplying clinical-grade NGS reagents and bioinformatics software to research labs via its Kailos Complete™ and Kailos Flex™ programs. The company's strategy centers on making advanced genetic analysis more accessible and customizable for both clinical and research settings, positioning itself in the growing markets of preventive oncology and personalized drug therapy.
View full company profileTherapeutic Areas
Other Hereditary Cancer Risk Drugs
| Drug | Company | Phase |
|---|---|---|
| GALEAS Hereditary (UKCA) | Nonacus | Approved |
| Cancer Genomics (CGx) Testing | Phi Life Sciences | Commercial |
| Hereditary Cancer Panel | Oxford Nanopore | RUO/Clinical Research |
| HANDLE Hereditary Cancer NGS Panel | Amoy Diagnostics | Commercial |